Prenetics Global Ltd Overview
Industry: Biotechnology & Medical Research
Sector: Healthcare
Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring system that allows users to take COVID-19 tests at point-of-care or at home utilizing the nucleic acid amplification test. The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an off-the-shelf at-home blood test; Circle Medical, a diagnostic testing product; and Circle One and F1x/Fem. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong. Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring system that allows users to take COVID-19 tests at point-of-ca Read MoreMavefund brings filings, fundamentals, valuation, price history and news for Prenetics Global Ltd into one research view. The sections below show what strengthens or weakens the research case.
Score
Reported Results
What the company reported, with filing details kept small.
Quarterly result summary
Revenue was $33.8M (+23.1% YoY). Cash was $56M.
Revenue
$33.8M
+23.1% YoY
Cash
$56M
reported
What changed
- Revenue +23.1% YoY to $33.8M.
Guidance / outlook
The Company expects to maintain gross margin efficiencies through the balance of 2026 as volumes scale further and supply chain initiatives mature.
Earnings release
Open filing
Source: SEC EDGAR company-filed earnings materials. Dates are shown only for verification; review the source filing before relying on extracted report details.
Other recent earnings materials
Prediction-grade evidence
Recent News
Company-relevant articles from sources that pass the Mave Signal relevance and reliability checks.
V.F (VFC) Could Be 16% Undervalued Following Its Pre Earnings Pullback
Headline from Yahoo Finance: V.F (VFC) Could Be 16% Undervalued Following Its Pre Earnings Pullback.
Ford Pre-Q2 Earnings Analysis: Buy the Stock Now or Wait?
Headline from Yahoo Finance: Ford Pre-Q2 Earnings Analysis: Buy the Stock Now or Wait?
Should Alphabet Stock Be in Your Portfolio Pre-Q2 Earnings?
Headline from Yahoo Finance: Should Alphabet Stock Be in Your Portfolio Pre-Q2 Earnings?
IBM Just Pre-Announced an Earnings Miss. The Reason Reveals Where AI Money Is Really Flowing.
Headline from The Motley Fool: IBM Just Pre-Announced an Earnings Miss. The Reason Reveals Where AI Money Is Really Flowing.
Abbott Q2 Earnings & Revenues Top Estimates, Stock Up in Pre-market
Headline from Yahoo Finance: Abbott Q2 Earnings & Revenues Top Estimates, Stock Up in Pre-market.
A&O Shearman hands partners £2.2mn as profits return to pre-merger levels
Headline from Financial Times: A&O Shearman hands partners £2.2mn as profits return to pre-merger levels.
Earnings Per Share
Score 3.00/5
Prenetics Global Ltd boasts a high score, as its Earnings Per Share (EPS) has demonstrated consistent growth over the past six years. Notable counterparts in the sector with high scores includes
Zoetis Inc
IQVIA Holdings Inc
Agilent Technologies Inc
In
Biotechnology & Medical Research industry
, Syneos Health
, Pluri Inc
, PureTech Health PLC
are companies with high ratings.
Return on Equity
Score 1.96/5
Prenetics Global Ltd exhibits a lower score in the Return on Equity (ROE) section, falling below the sector median value and indicating a comparatively weaker performance in this metric. The top companies in the same sector include
Zoetis Inc
IQVIA Holdings Inc
Agilent Technologies Inc
0%
10%
20%
30%
40%
ROE
Company —
Sector Median —
0%
10%
20%
30%
40%
ROE
Company —
Sector Median —
0%
10%
20%
30%
40%
ROE
Company —
Sector Median —
0%
10%
20%
30%
40%
ROE
Company —
Sector Median —
Metric chart temporarily unavailable.
Net Margin
Score 2.21/5
Prenetics Global Ltd
olds a low score as its net margin consistently trails below the sector median value and doesn't exhibit continuous growth over the last six years; notable companies in the sector with commendable scores include
Zoetis Inc
IQVIA Holdings Inc
Agilent Technologies Inc
0%
10%
20%
30%
40%
Net Margin
Company —
Sector Median —
0%
10%
20%
30%
40%
Net Margin
Company —
Sector Median —
0%
10%
20%
30%
40%
Net Margin
Company —
Sector Median —
0%
10%
20%
30%
40%
Net Margin
Company —
Sector Median —
Metric chart temporarily unavailable.
Leverage
Score 3.27/5
Prenetics Global Ltd
attains a commendable score in the category due to its lower leverage ratio over the past six years in comparison to the sector median value. Additionally, other notable companies in the same sector, such as
Zoetis Inc
IQVIA Holdings Inc
Agilent Technologies Inc
, also exhibit high scores.
0
1
2
3
4
Leverage
Company —
Sector Median —
0
1
2
3
4
Leverage
Company —
Sector Median —
0
1
2
3
4
Leverage
Company —
Sector Median —
0
1
2
3
4
Leverage
Company —
Sector Median —
Metric chart temporarily unavailable.
Financial Statements
Company-reported SEC EDGAR facts organized into the three core statements.
Verified SEC statements load when this section enters view.
Source: SEC EDGAR companyfacts. Values are standardized company filings for research support, not personalized financial advice.
Financial Ratio
Yearly
Quarterly
Financial
Profitability
Growth
Cash Flow
Financial Health
Efficiency Ratios